# A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control

> **NCT00351143** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 274 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** salmeterol/fluticasone propionate 50/250 µg + 3 training sessions of compliance enhancement training
- **DRUG:** salmeterol/fluticasone propionate 50/250 µg

## Key facts

- **NCT ID:** NCT00351143
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07-26
- **Primary completion:** 2007-06-13
- **Final completion:** 2007-06-13
- **Target enrollment:** 274 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351143, "A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00351143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*